Cargando…
Disease-related patterns of in vivo pathology in Corticobasal syndrome
PURPOSE: To assess disease-related patterns of in vivo pathology in 11 patients with Corticobasal Syndrome (CBS) compared to 20 healthy controls and 33 mild cognitive impairment (MCI) patients due to Alzheimer’s disease. METHODS: We assessed tau aggregates with [(18)F]AV1451 PET, amyloid-β depositio...
Autores principales: | Niccolini, Flavia, Wilson, Heather, Hirschbichler, Stephanie, Yousaf, Tayyabah, Pagano, Gennaro, Whittington, Alexander, Caminiti, Silvia P., Erro, Roberto, Holton, Janice L., Jaunmuktane, Zane, Esposito, Marcello, Martino, Davide, Abdul, Ali, Passchier, Jan, Rabiner, Eugenii A., Gunn, Roger N., Bhatia, Kailash P., Politis, Marios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208819/ https://www.ncbi.nlm.nih.gov/pubmed/30090966 http://dx.doi.org/10.1007/s00259-018-4104-2 |
Ejemplares similares
-
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
por: Yousaf, Tayyabah, et al.
Publicado: (2019) -
Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019) -
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Pagano, Gennaro, et al.
Publicado: (2017) -
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019) -
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2022)